This is a working overview of GHRH analog, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-12-11. Anything still debated is marked as such rather than presented as settled.
Tesamorelin occupies a narrow position among agents that act on the growth hormone axis. Unlike growth hormone itself, which is given as replacement, it stimulates the pituitary to release the hormone in pulses, so the downstream increase in insulin-like growth factor 1 depends on intact somatotroph function. Other peptides in the same family include shorter GHRH fragments and synthetic secretagogues with different stability profiles. Several points remain unresolved, including whether the reduction in visceral fat translates into fewer cardiovascular events, what happens to metabolic markers after long-term use, and how the drug compares with lifestyle or surgical approaches.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone family and contains the same forty-four amino acid sequence as endogenous GHRH, extended at the amino terminus by a trans-3-hexenoyl group. That small fatty acid modification protects the peptide from rapid cleavage by dipeptidyl peptidase-4, the enzyme that shortens the half-life of native GHRH to only a few minutes. Chemically the compound is produced by solid-phase peptide synthesis, purified by chromatography, and supplied as a sterile lyophilized powder for reconstitution.
Tesamorelin binds to growth hormone-releasing hormone receptors on the surface of pituitary somatotroph cells. This binding activates adenylate cyclase, raising intracellular cyclic AMP levels and triggering the release of growth hormone into circulation. The elevated growth hormone then stimulates hepatic production of insulin-like growth factor 1. Because the effect is mediated through the endogenous axis, secretion remains subject to feedback regulation. This distinguishes it from direct growth hormone administration, which bypasses pituitary control entirely.
Clinical investigation has focused on HIV-associated lipodystrophy, a condition in which antiretroviral therapy contributes to abnormal fat distribution. Excess visceral adipose tissue accumulates in the abdomen while peripheral fat may be lost. Tesamorelin was evaluated for reducing this visceral fat depot, with trials measuring changes in abdominal fat by imaging rather than by body weight alone. The rationale rests on the known lipolytic effects of growth hormone. Effects on visceral fat are documented, while long-term outcomes regarding cardiovascular risk remain less clearly established.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, composed of 44 amino acids. It was designed to retain the biological activity of the native hormone while resisting rapid enzymatic degradation. The compound is classified as a growth hormone secretagogue and belongs to the broader family of hypothalamic releasing factors. In research and clinical settings, it is studied for its ability to stimulate pituitary growth hormone release. Its structure includes a modification at the N-terminus that contributes to an extended half-life relative to native growth hormone-releasing hormone.
| Property | Value | Notes |
|---|---|---|
| Peptide class | Synthetic GHRH analogue | 44 residues; N-terminal trans-3-hexenoyl group |
| First approval year | 2010 | United States; HIV-associated abdominal fat accumulation |
| Administration route | Subcutaneous injection | Abdominal site; clinician-administered or self-injected |
| Common synonyms | TH9507; tesamorelin acetate | Development code and acetate salt form |
| Originator | Canadian biotechnology firm | Original developer and regulatory sponsor |
Metabolic interest in this compound centers on fat distribution rather than on hormone levels alone. Imaging trials in adults with excess abdominal fat report reductions in visceral adipose tissue, while subcutaneous depots change comparatively little. Growth hormone and IGF-1 are presumed to carry the effect, but the separate contribution of each is not firmly established. Whether these changes persist after treatment stops, and whether they alter longer-term health outcomes, remain open questions that published work does not answer consistently.
Tesamorelin is a synthetic peptide of forty-four amino acids whose sequence reproduces human growth hormone-releasing hormone. Its distinguishing feature sits at the amino terminus, where a trans-3-hexenoyl group replaces the free amine. That acylation slows cleavage by dipeptidyl peptidase IV, an enzyme that otherwise removes the first two residues and inactivates the natural hormone quickly. The modified peptide therefore persists longer in circulation while keeping the same receptor target. It is handled as a lyophilized solid and dissolved shortly before use.
The hexenoyl cap slows the enzyme step that trims the amino terminus of native GHRH, the same step that shortens its active lifetime in circulation. As a result, the modified peptide persists longer in plasma than the unmodified hormone in side-by-side comparison. Receptor activity stays broadly comparable, because the added group sits away from the residues that contact the binding site. This combination, preserved receptor activity with reduced degradation, explains why the analog was developed instead of the native sequence.
Several compounds share the GHRH framework, including sermorelin, the shorter 1-29 fragment, and other analogs built on the full 1-44 chain. Naming follows a common convention: a stem that identifies the peptide plus a suffix marking analog status. Reports may describe tesamorelin by its sequence fragment, as a GHRH(1-44) analog, or by its amino-terminal modification. Indexing the compound therefore requires searching all of these forms, since some older literature predates the current international nonproprietary name.
The peptide is synthesized chemically rather than extracted from biological sources. Solid-phase synthesis builds the chain from the C-terminus toward the N-terminus, after which the hexenoyl group is attached. Purity is typically assessed by high-performance liquid chromatography, and identity is confirmed by mass spectrometry. Regulatory review of the finished product focuses on these analytical controls, since small deviations in sequence or modification can change biological activity. Questions about long-term effects on the pituitary axis remain areas of continued investigation.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone (GHRH) family. Its sequence corresponds to the fully active 44-amino-acid form of human GHRH, with a single structural modification: the addition of a trans-3-hexenoyl group at the N-terminus. That modification is not found in the naturally occurring hormone and was introduced deliberately during development to improve stability against enzymatic degradation. The compound is therefore best described as a stabilized analogue rather than a naturally occurring peptide.
== Epidemiology == CGD affects about 1 in 200,000 people in the United States, with about 20 new cases diagnosed each year. Chronic granulomatous disease affects all people of all races; however, there is limited information on prevalence outside of the United States. One survey in Sweden reported an incidence of 1 in 220,000 people, while a larger review of studies in Europe suggested a lower rate: 1 in 250,000 people.
== Introduction == Theoretical calculation for the proton and neutron drip lines show that there would be about 7,000 nuclides that are between the drip lines, and containing 2 to 120 protons. There are presently 251 known stable nuclides. Many of these in theory could decay through spontaneous fission, alpha decay, double beta decay, etc. with a very long half-life, but this has not yet been observed. Thus, the number of stable nuclides is subject to change if some of these 251 have radioactive decay observed in the future. In this article, the "stable" nuclides are divided into three tables: one for nuclides that are theoretically stable (meaning no decay mode is possible) except to spontaneous fission, which is not considered plausible in this mass range; one for nuclides that can theoretically undergo forms of decay other than spontaneous fission but have no published lower bound on lifetime from experimental evaluations; and one for nuclides that can theoretically decay and have been examined without detecting any decay, allowing a lower bound to be published. In this last table, where a decay has been predicted theoretically but never observed experimentally (either directly or by finding an excess of the daughter), the theoretical decay mode is given in parentheses, and "> (lifetime in years)" is shown in the half-life column to show this lower limit in scientific notation. Such nuclides are considered to be "stable", also called "observationally stable" indicating the tentative nature of the conclusion, until some decay has been observed.
Biological differences in fractionation stem not only from biochemical differences between different molecules, but also from physiological differences between different organisms. For example, the δDs of multiple leaf wax molecules are enriched in shrubs (median ~ −90‰) relative to trees (median ~ −135‰), which themselves are enriched relative to both C3 (median ~ −160‰) and C4 grasses (median ~ −140‰). Between individual species, substantial variation in δD has been documented. Other physiological factors that contribute to variable leaf wax δD values include the seasonal timing of leaf development, response to external stress or environmental variability, and the presence or absence of stomata It can be difficult to distinguish between physiological factors and environmental factors, when many physiological adaptations are directly related to environment. Several environmental factors have been shown to contribute to leaf wax δD variability, in addition to environmental effects on the δD of source water. Humidity is known to impact lipid δD at moderate humidity levels, but not at particularly high (>80%) or low (<40%) humidity levels, and a broad trend of enriched δDs, meaning smaller εl/w, is seen in arid regions. Temperature and sunlight intensity, both correlated to latitude, have strong effects on the rates of metabolism and transpiration, and by extension on εl/w. Also, the average chain length of leaf wax molecules varies with geographic latitude, and εl/w has been shown to increase with increasing chain length.
Meanwhile, General Armada, another of the conspirators, tried to get the king to authorize him to appear on his behalf in the Congress of Deputies, but Juan Carlos I refused. In spite of this, Armada went to the Congress where he met with Tejero, to whom he explained his plan to form a concentration government presided by him and asked him to let him address the deputies. Tejero flatly refused because he wanted a purely military government. At one o'clock in the morning, the king, dressed as Captain General as supreme chief of the Armed Forces, addressed the country condemning the military coup and defending the democratic system. It was "the decisive moment to defeat the coup". Two hours later, Milans del Bosch ordered the withdrawal of his troops and the next morning Tejero surrendered, releasing the government and the deputies. The coup of "23-F" had failed. Shortly after, demonstrations in support of the Constitution and in defense of democracy were called, which were the largest of those held up to that time.
Sources: en.wikipedia.org
Poppy tea contains two groups of alkaloids: phenanthrenes (including morphine and codeine) and benzylisoquinolines (including papaverine). Of these, morphine is the most prevalent comprising 8%–14% of the total. Its effects derive from the fact that it binds to and activates mu opioid receptors in the brain, spinal cord, stomach and intestine. Dried Papaver somniferum capsules and stems will, if harvested and dried by the usual protocol, contain significantly lower quantities of thebaine than opium made from latex as well as somewhat more codeine. When ingested, thebaine causes nausea, vomiting, and myoclonus. Thebaine is an important precursor for manufacture of pharmaceuticals, and is more concentrated in the roots of Papaver somniferum than elsewhere. Other species of poppies, numbering in the hundreds, do not contain morphine or codeine in useful amounts, but may contain non-narcotic alkaloids like protopine, sanguinarine or berberine.
== Etymology == The word analgesic derives from Greek an- (ἀν-, "without"), álgos (ἄλγος, "pain"), and -ikos (-ικος, forming adjectives). Such drugs were usually known as "anodynes" before the 20th century.
== Morphology == This bacterium has a cell diameter is of 0.8–1.0 micrometers but does not have a definite length because of its multicellular filamentous structure. The bacterium is red to reddish-brown forms distinct red bacterial mats in the natural environment. R. castenholzii lacks internal vesicles, internal membranes, and complex structures. This species has gliding motility.
== Comparison with western philosophy == The concept of pratītyasamutpāda has also been compared to Western metaphysics, the study of reality. Schilbrack states that the doctrine of interdependent origination seems to fit the definition of a metaphysical teaching, by questioning whether there is anything at all. Hoffman disagrees, and asserts that pratītyasamutpāda should not be considered a metaphysical doctrine in the strictest sense, since it does not confirm nor deny specific entities or realities. The Hellenistic philosophy of Pyrrhonism parallels the Buddhist view of dependent origination, as it does in many other matters (see: similarities between Phyrrhonism and Buddhism). Aulus Gellius in Attic Nights describes how appearances are produced by relative interactions between mind and body and how there are no self-dependent things. The ancient Commentary on Plato's Theaetetus also defends a kind of relativism which states that nothing has its own intrinsic character. Jay L. Garfield states that Nagarjuna's Mulamadhyamikakarika uses the causal relation to understand the nature of reality, and of our relation to it. This attempt is similar to the use of causation by Hume, Kant, and Schopenhauer as they present their arguments. Nagarjuna uses causation to present his arguments on how one individualizes objects, orders one's experience of the world, and understands agency in the world.
=== Saint Ansbert of Rouen === Earlier reports of stigmatics do exist, however there is a lack of consensus on how the concept of stigmata was understood pre-Saint Francis. St. Ansbert of Rouen (d. 695 AD) could be considered the earliest stigmatic due to the claims of witnesses following his death, first recorded by an anonymous monk in the mid-8th century AD in Vita Sancti Ansberti:
Sources: en.wikipedia.org
== Aggregate processes == While the underlying process of radioactive decay is subatomic, historically and in most practical cases it is encountered in bulk materials with very large numbers of atoms. This section discusses models that connect events at the atomic level to observations in aggregate.
Ethylene oxide causes acute poisoning, accompanied by a variety of symptoms. Central nervous system effects are frequently associated with human exposure to ethylene oxide in occupational settings. Headache, nausea, and vomiting have been reported. Peripheral neuropathy, impaired hand-eye coordination and memory loss have been reported in more recent case studies of chronically-exposed workers at estimated average exposure levels as low as 3 ppm (with possible short-term peaks as high as 700 ppm). The metabolism of ethylene oxide is not completely known. Data from animal studies indicate two possible pathways for the metabolism of ethylene oxide: hydrolysis to ethylene glycol and glutathione conjugation to form mercapturic acid and meththio-metabolites. Ethylene oxide easily penetrates through ordinary clothing and footwear, causing skin irritation and dermatitis with the formation of blisters, fever, and leukocytosis. Toxicity data for ethylene oxide are as follows:
Allosteric activation by glucose-6-phosphate, which acts as an effector, stimulates glycogen synthase, and glucose-6-phosphate may inhibit the phosphorylation of glycogen synthase by cyclic AMP-stimulated protein kinase.
When a dry porous medium is brought into contact with a liquid, it will absorb the liquid at a rate which decreases over time. When considering evaporation, liquid penetration will reach a limit dependent on parameters of temperature, humidity and permeability. This process is known as evaporation limited capillary penetration and is widely observed in common situations including fluid absorption into paper and rising damp in concrete or masonry walls. For a bar shaped section of material with cross-sectional area A that is wetted on one end, the cumulative volume V of absorbed liquid after a time t is
Sources: en.wikipedia.org
It is a laboratory-made peptide of forty-four amino acids whose sequence matches human growth hormone-releasing hormone, with a modified amino terminus. The modification is a short unsaturated fatty acid chain attached to the first residue. This change slows enzymatic breakdown and lengthens the time the peptide stays active in circulation.
The clinical program was designed around HIV-associated lipodystrophy, a condition in which fat accumulates abnormally around the internal organs. Trials enrolled that specific population, so the evidence base covers it rather than the general population. Regulators approved the drug for the studied indication only, and promotion outside it is not permitted.
Growth hormone therapy supplies the finished hormone directly, while this peptide acts upstream and asks the pituitary to secrete its own. That difference means the response depends on a functioning pituitary and on the body's normal feedback loops. It also means the circulating hormone profile is pulsatile rather than a flat, injected level.
It is a synthetic analog of growth hormone-releasing hormone, a hypothalamic peptide. It functions as a growth hormone secretagogue acting at pituitary receptors. The classification separates it from direct growth hormone products.